Table 2.
Antipsychotic use by line of therapy
| Prescribed antipsychotic | Any line of therapy, n(%) | First line, n(%) | Second line or subsequent lines, n(%) |
|---|---|---|---|
| Treatment episodes, n (%)a | 8,249 (100%) | 6,872 (100%) | 2,013 (100%) |
| Unique patients, n | 6,740 | 6,740 | 1,297 |
| Atypical Oral | 5,139 (62%) | 4,883 (71%) | 428 (21%) |
| Typical LAT | 1,608 (19%) | 1,146 (17%) | 684 (34%) |
| Typical Oral | 751 (9%) | 511 (7%) | 319 (16%) |
| Atypical LAT | 541 (7%) | 173 (3%) | 428 (21%) |
| Clozapine | 210 (3%) | 159 (2%) | 684 (34%) |
aNote: Total number of non-unique patients is higher than unique patients due to polypharmacy and patients re-entering the data set on different treatments. The denominator for percentage calculations is the total number of non-unique patients